Year: 2003 Source: FDA Consumer, v.37, no.2, (March/April 2003), p.5 SIEC No: 20030779

This article discusses the approval of Clozaril by the American Food & Drug Administration for the reduction of recurrent suicidal behavior. Information about schizophrenia, for which the drug was originally prescribed, is included. Side effects of Clozaril are listed. (SC)